000			03113cam a2200325 a 4500
003			EG-GiCUC
008			170925s2016 ua d f m 000 0 eng d
040			_aEG-GiCUC _beng _cEG-GiCUC
041	0		_aeng
049			_aDeposite
097			_aM.Sc
099			_aCai01.11.07.M.Sc.2016.Am.R
100	0		_aAmira Adel Elsaeed Elsobky
245	1	0	_aRole of T-cells related cytokines (IL-35 and IL-12) in the pathogenesis of persistent and chronic immune thrombocytopenia / _cAmira Adel Elsaeed Elsobky ; Supervised Nehad Mohamed Tawfik , Noha Mohamed Elhusseiny , Mohamed Ahmed Fateen
246	1	5	_aدور السيتوكينات المرتبطة بخلايا تى المناعية (انترلوكين 12و انترلوكين 35) فى حدوث مرض نقص الصفائح الدموية المناعى الدائم و المزمن
260			_aCairo : _bAmira Adel Elsaeed Elsobky , _c2016
300			_a134 P. : _bcharts ; _c25cm
502			_aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Clinical and Chemical Pathology
520			_aIL-12 is the first cytokine shown to be able to drive the differentiation of naive T-cells into Th1 cells, since IL-12 can induce or promote the generation of pro-inflammatory Th1 cells that are involved in the progress of many autoimmune diseases. Interleukin 35 (IL-35) is the newest identified member of the interleukin-12 cytokine family. IL-35 appears to affect the immunological self-tolerance by modulating T cells and immune-regulatory cytokines. Our study aimed at studying the plasma levels of T-cells related cytokines (IL-35, IL-12) and their clinical relevance in patients with persistent and chronic ITP. This study was carried out on 90 subjects divided into two groups the first group consists of 45 patients with chronic and persistent ITP, the second group consists of 45 normal healthy controls. All participants were subjected to careful history taking, thorough clinical examination and appropriate laboratory investigations including CBC and assessment of serum levels of IL-12 and IL-35 using ELISA technique. Our results revealed that as regards to interleukin 12 levels, there was a statistically significant difference between the cases and control groups where the cases levels were significantly higher. As regards to interleukin 35 levels, also there was a statistically significant difference between the two studied groups where the cases levels were significantly higher. This suggests that IL-12 and IL-35 may have a role in the pathogenesis of ITP through induction or promotion of the generation of pro-inflammatory Th1cells in case of IL-12, or through altering the immune self tolerance through regulatory T-cells in case of IL-35
530			_aIssued also as CD
653		4	_aImmune thromb cytopenia
653		4	_aInterleukin 12
653		4	_aInterleukin 35
700	0		_aMohamed Ahmed Fateen , _eSupervisor
700	0		_aNehad Mohamed Tawfik , _eSupervisor
700	0		_aNoha Mohamed Elhusseiny , _eSupervisor
905			_aNazla _eRevisor
905			_aSamia _eCataloger
942			_2ddc _cTH
999			_c62546 _d62546